Company Name:Zogenix Inc.
CEO: Stephen J. Farr

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.


Key numbers

Market Capitalization:1998113250
Shares Outstanding: 44255000
Float: 43370386.805
Next Earning Date:2020-03-04
TTm EPS: -9.0068
TTm Dividend Rate:
200 days moving average:44.61
50 days moving average: 42.61
One day percent Change: 1.6



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,